Skip to main content

Daytime noninvasive ventilatory support for patients with ventilatory pump failure: a narrative review


Over the past three decades, the use of noninvasive ventilation or “NIV” to assuage symptoms of hypoventilation for patients with early onset or mild ventilatory pump failure has been extended to up to the use of continuous noninvasive ventilatory support (CNVS) at full ventilatory support settings as a definitive alternative to tracheostomy mechanical ventilation. NVS, along with mechanical insufflation-exsufflation, now provides a noninvasive option for the management of both chronic and acute respiratory failure for these patients. The most common diagnoses for which these methods are useful include chest wall deformities, neuromuscular diseases, morbid obesity, high level spinal cord injury and idiopathic, primary or secondary disorders of the ventilatory control. Thus, NVS is being used in diverse settings: critical care units, medical wards, at home, and in extended care. The aim of this review is to examine the techniques used for daytime support.


Respiratory muscle insufficiency/failure is defined by the inability to maintain adequate blood oxygenation and carbon dioxide removal [1, 2]. The underlying pathophysiologic processes causing it are quite different from those typically treated by physicians. Instead of lung/airways disorders that result primarily in oxygenation impairment and air trapping, for patients with ventilatory pump failure hypoxia is secondary to inspiratory and/or expiratory muscle impairment that results in hypoventilation and airway mucus congestion [3, 4]. When patients’ respiratory muscles cannot sustain autonomous respiration, the use of mechanical ventilation has become [5] the cornerstone of modern pulmonary medicine and critical care.

Non-invasive ventilation or “NIV” has become synonymous with continuous positive airway pressure and low span bi-level positive airway pressure to treat sleep-disordered breathing (central and obstructive apneas) and acute respiratory failure for patients with lung disease [5,6,7,8,9,10,11]. Observational and randomized controlled studies now strongly support NIV for patients with mild neuromuscular disease (NMD) who are not completely respirator dependent [12,13,14,15,16,17,18,19]. Furthermore, when considering NIV, for patients with lung diseases, airway clearance therapy is addressed [20,21,22]. Standardized guidelines have been accepted worldwide for the initiation of nocturnal NIV [23,24,25,26,27,28,29,30,31,32]. However, for patients with ventilatory pump failure advancing disease can result in patients extending sleep NIV into daytime hours and becoming hypercapnic because of the inadequacy of the pressure support settings. These patients can also require mechanical in-exsufflation to increase cough flows [20,21,22]. The paucity of literature focused on this topic and failure to recognize the deficiencies in the administration of NIV motivated this review, which aims to highlight means for providing up to continuous noninvasive ventilatory support (CNVS).

There is NVS and invasive mechanical ventilation whether via translaryngeal or tracheostomy tube (TMV) [5,6,7,8, 33,34,35,36]. However, 80% of mortality in some diagnoses of patients using tracheostomy ventilation has been reported to be due to the tube itself, rather than directly to the disease [37]. On the other hand, while tracheostomy ventilation is associated with increased mortality and diminished quality of life [38], CNVS is permitting patients with no autonomous breathing ability and little to no vital capacity (VC) with diagnoses including spinal muscular atrophy type 1 more than 2 decades [39], post-polio survivors to survive for over 65 years [40], Duchenne muscular dystrophy to survive into their 50s on CNVS for over 25 years [41], etc.. Patients who require daytime NVS can eventually require it around-the-clock with little to no autonomous ability to breathe. For this, full respiratory support settings are necessary and “NIV” or typical bi-level positive airway pressure is inadequate. Thus, CNVS refers to the administration of full ventilatory support settings day and night [9, 13]. Its benefits include improving gas exchange, symptoms [42], quality of life [43,44,45], decreasing the incidence of pneumonia [46], facilitating ventilator weaning, resting respiratory muscles, and supporting life for people indefinitely without need to resort to tracheotomy [46]. Tracheostomy tubes, on the other hand, tend to increase ventilator dependence, reduce quality of life, and are associated with reactive depression [47,48,49,50].

A literature review and manual selection using PubMed/Medline was undertaken through May 2019. Search terms used were noninvasive ventilation, noninvasive ventilatory support, home ventilation, diurnal or daytime non-invasive ventilation and neuromuscular. Retrospective, prospective, controlled, and non-controlled studies were included. Abstracts or clinical cases were excluded.

Introduction of daytime support

The VC is commonly used to assess respiratory muscle weakness. A VC less than 50% [8] of predicted normal or forced expiratory volume in 1 s less than 40–50% predicted along with clear symptoms of sleep hypoventilation, indicate need to introduce sleep NVS. Maximal inspiratory pressure or sniff nasal pressure less than 30–40 cm H2O can also be helpful [21,22,23,24,25,26,27,28,29]. A decrease in VC of 25% or more when going from sitting to supine indicates diaphragm weakness and explains respiratory orthopnea and need for sleep NVS [51]. Typical symptoms of hypoventilation include fatigue, dyspnea, morning headaches, and hypersomnolence. Corroborating signs can include PaCO2 greater than 45 mmHg, nocturnal oximetry saturation < 88% for 5 consecutive minutes [21], and end-tidal CO2 > 47 mmHg [52]. Thus, the indication to initiate sleep NVS is symptomatic hypoventilation in the presence of any indications of respiratory muscle dysfunction. Typically, with advancing disease and decreasing VC, sleep NVS users become dyspneic when NVS is discontinued in the morning and nasal NVS is extended NVS into daytime hours [45, 52,53,54,55,56,57,58,59,60]. While sleep NVS initially normalizes daytime blood gases, further muscle deterioration causes increasing daytime hypercapnia such that when O2 desaturation occurs below 95% dyspnea results in ever increasing use of NVS throughout daytime hours [57,58,59,60,61].

Daytime support methods

Mouthpiece and nasal NVS

Mouthpiece NVS was first described for CNVS in 1953 to permit iron lung users, with little to no autonomous ability to breathe, to leave iron lungs during the day. Subsequently they often began to refuse to return to iron lungs for sleep so they used mouthpiece NVS for CNVS [62, 63]. Their ventilator settings were typically pressure control at 18 to, at times for obese patients, 35 or more cm H2O for daytime as well as sleep NVS. When volume cycling portable ventilators came onto the market in 1976, CNVS was typically delivered at preset volumes of 800 to 1500 ml. The patients took as much of the air as desired for each breath. Besides normalizing PaO2, PaCO2, and sleep quality, CNVS indisputably prolongs survival for patients with little or no autonomous ability to breathe, 257 such patients were described in 1993 [64].

Mouthpiece NVS is provided via 15 or 22 mm angled, or straw-type, mouthpieces accessible to the mouth by being supported by a flexible support arm such that the patient can access it with the lips as needed (Fig. 1). Patients can trigger the breaths by creating a small negative pressure (sip and breathe) or placing the mouth on the mouthpiece (Kiss Trigger, Trilogy Ventilator, Respironics Inc., Murrysville Pa) [61]. Any mode can be used but volume preset ventilation with an active circuit permits active lung volume recruitment (“air-stacking”). This is the glottis retention of consecutively delivered volumes of air until a deep lung volume is attained. This maintains pulmonary compliance, increases cough flows and speech volume. A problem can be false alarms when using open circuits [61]. Several new portable ventilators have now a mouthpiece ventilation mode (“MPV mode”) that minimizes false alarms [65,66,67,68]. Although mouthpiece NVS facilitates speaking, eating, swallowing, and coughing, the patient can discontinue it as desired. There is no dyspnoea or transient oxyhemoglobin desaturations between grabbing the mouth piece for supported breaths when NVS settings are used [68]. For example, if normal minute ventilation is 6000 ml, this can be taken in by 12 breaths of 500 ml or 4 of 1500 ml. The latter affords more than 10 s for chewing and swallowing.

Fig. 1

Mouthpiece ventilation

The 15 mm angled mouthpiece and straw-type mouthpiece are easy to grip [65, 68]. Khirani et al. [67] evaluated 209 patients, 30 using MPV modes, by questionnaire. These patients associated mouthpiece NVS with less dyspnoea and fatigue and greater facility in speaking and eating. In another study, Nicolini et al. [68] reported an improvement in clinical symptoms, blood gases, and in nocturnal ventilation, sleep related parameters and Health Related Quality of Live scores for kyphoscoliotic patients. While frequent or prolonged disconnections inducing apnoea/hypopnea or hypoventilation have been noted [63, 68], this only occurs when less than NVS settings are used.

Assist control pressure or volume preset ventilation modes with minimal back-up rates and extreme alarm settings are used to avoid nuisance alarms. The Kiss Trigger™ of the Trilogy™ ventilator permits 0 back-up rates [69].

While in the 1950s and 60s 15 mm angled mouthpiece NVS was used around-the-clock, once a lip cover phalange came onto the market in 1964 this secured the mouthpiece and permitted the delivery of air with little to no mouth leak during sleep (Fig. 1). This was the principal method of sleep NVS until Bach, Alba, Mosher, and Delaubier described nasal NVS in 1987. Today, 3 out of 4 patients prefer nasal over oral interfaces for sleep NVS [70, 71]. Recently, over 700 CNVS dependent muscular dystrophy and amyotrophic lateral sclerosis patients were reported using daytime mouthpiece NVS [72]. However, for those for whom lips are too weak or neck movement inadequate to grab a mouthpiece, daytime nasal NVS has always been preferred over resort to tracheotomy [71].

Skin breakdowns typically only occur when a single nasal interface is used around-the-clock [73, 74]. Daytime NVS can cause airway and mouth dryness that can negatively impact on quality of life and cause airway congestion and possibly inadequate gas-exchange and atelectasis [53]. With typical daytime mouthpiece NVS, however, there is no interface intolerance, difficulty speaking, expectorating or eating, facial deformities, or claustrophobia [16]. While skin discomfort, eye irritation, and other difficulties have been associated with the use of nasal and oronasal interfaces for sleep, none of this is relevant for daytime mouthpiece NVS users or nasal NVS users who use nasal prongs for daytime NVS and daytime mouthpiece or nasal prong NVS users.


Currently, there are many interfaces commercially available [74, 75] . They come in a variety of styles and sized i.e. nasal, oro-nasal, full-face, mouthpiece or orophylange. Each has advantages and disadvantages.

  • Mouthpiece: Straw-type or 15 mm angled mouthpieces are grabbed with the lips and teeth [76]. No pressure over the bridge of the nose or need for headgear. It permits use on demand and active lung volume recruitment (air stacking). There are no downsides for daytime use other than mouth and airway dryness. The most commonly used mouthpiece is the 15 mm angled mouthpiece from Respironics Inc. (Murrysville, Pa) [16, 61, 76].

  • .Nasal interface (mask): Although triangular nasal interfaces that cover only the nose are used for sleep, nasal prongs inserted into the nostrils, pillows, nose tip covering interfaces are greatly preferred for daytime support although they may cause nostril dryness. These avoid claustrophobia, permit eating and speech and mouth leaks are not a problem during daytime use. Triangular interfaces cause nasal bridge pressure.

  • Oronasal interface (mask): These cover both nose and mouth. Mouth and nasal leaks are greatly reduced. They requires less patient cooperation but interfere with speech, eating, and expectoration. They increase risk of rebreathing and cannot be used during meals.

  • Full-face interface (mask): These cover mouth, nose, and eyes. They can be useful for sleep but expose patients to eye redness and dryness; they interfere with speech, eating, and expectoration and can not be used for ongoing daytime NVS [75, 77, 78].

  • Helmet: A transparent air-tight helmet rather than orofacial interface. These permit speech but the increased dead space and possibility of axillary skin injury prevent its ongoing daytime use [74, 75].

Body ventilators

The intermittent abdominal pressure ventilator

In 1938 the intermittent abdominal pressure ventilation,or “Pneumobelt, was described by C. J. McSweeney as the Bragg-Paul Pulsator. It was used by 34 patients with acute diphtheritic respiratory muscle paralysis. In the 1940s, it was improved by Dr. Alvin Barach and his engineer William Smith. After 1946, it became widely used for daytime non-invasive ventilatory support [79,80,81,82,83,84]. It consists of a corset with an elastic inflatable bladder that fits over the abdomen. The bladder is connected by a hose to a ventilator that deliver up to 2.5 l of air to the bladder and, thereby, to the abdominal wall [82, 83]. This elevates the diaphragm to cause expiration below the functional residual capacity. When the bladder deflates, the diaphragm descends by gravity and inspiration occurs passively. Typically, 300 to 1,000 ml of air are delivered [81]. It went off the market as tracheotomies became the convention but is back on the market today (Dima Inc., Italy). New models avoid clothing catching on the corset buckles and are more comfortable. They are now lightweight, comfortable, easy to done and fit and employ velcro for fastening (Fig. 2) [55]. Nevertheless, mouthpiece NVS users generally prefer mouthpiece NVS because of the greater inspiratory volumes that can be taken in.

Fig. 2

Intermittent abdominal pressure ventilation by PBelt

Limitations include the fact that its efficiency depends upon the surface area of the chest and the abdomen covered. Since the increase of lung volume is generated by gravity, it is effective only in the sitting position [82], or at least at an angle of 30° or greater [44]. It is usually not sufficiently effective for very obese or severely scoliotic patients [79]. The current device on the market allows the user to set the following parameters: - PBelt (pressure inside the PBAir®); −Tinsp (real inspiratory time when the diaphragm descends); − Frequency (respiratory rate); and -Rise Time (time to reach the PBelt). Thus, “Pneumobelt” use is inconspicuous, comfortable, simple to do and use and leaves the face/mouth/nose, and neck free. It is portable and easily installed onto a wheelchair. It facilitates speech, belching to pass flatus and abdominal compression to increase cough flows to help clear secretions. Patients learn to close the glottis just prior to an abdominal compression to increase cough flows. It is also useful for constipation [82]. It also leaves the field of vision free and allows the patient a more normal sense of smell by eliminating facial and invasive interfaces that may be colonized by pathogenic bacteria. Thus, it favors oral nutrition and digestion [82]. In rare cases it is used for sleep with patients sitting [83]. Disadvantages can be food regurgitation during meals (rarely), catching clothing on straps and Velcro closures, redness of the bony prominences, and impossibility to shower or to bath when using it [83, 84]. Furthermore, regular follow up is important because it can become less effective with time [83, 84]. Its use has also recently been reported for patients with cervical myelopathies [55]. For all these reasons, the “Pneumobelt” is again becoming an important alternative for the patients requiring daytime support.

Negative-pressure ventilation

Negative pressure ventilation was widely used for both sleep and daytime ventilatory support as iron lungs, pancho, pneumosuit, and pneumowrap ventilators before the advent of NVS in the 1950s. The chest cuirass is a rigid shell fitting over the anterior portion of the chest or over the chest and abdomen. The pneumowrap, poncho, pneumosuit ventilators consisted of a parka suspended over a rigid plastic or metal chest piece. The cuirass and wrap-style interfaces are powered by large negative pressure ventilators. While mouthpiece NVS facilitates speech, eating, maximizes coughing, and raising one’s voice, negative pressure body ventilators don’t.

Only the cuirass or chest shell ventilator can be used for daytime support for patients in wheelchairs [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88]. The ventilator assumes part of the patient’s work of breathing and therefore respiratory muscles can rest but not so much as using NVS [89]. During sleep all negative pressure body ventilators cause severe obstructive apneas [90, 91].

The biphasic chest shell ventilator (Hayek Inc., England) can certainly provide daytime ventilatory assistance for patients without severe scoliosis, however it is unsightly, restrictive on mobility, and no more effective than “pneumobelts” at providing large tidal volumes for daytime ventilatory support. It has never been preferable to “pneumobelt” or mouthpiece NVS [82].

Glossopharyngeal breathing (GPB)

Patients with at least some bulbar muscle function can often learn to glossopharyngeal breath for ventilator free breathing as well as for “auto” air stacking. This involves the tongue pistoning boluses of air past the glottis and into the lungs. It can be done with the mouth open or, in some cases, via the nose with the mouth closed [92,93,94,95]. It can improve speech volume and cough efficacy [95]. The technique can allow increased periods off of NVS or even all day autonomous ability for adept patients despite having little to no VC [96,97,98,99].

Mechanical insufflation-exsufflation

Unfortunately, with the paradigm shift to invasive ventilatory support in the late 1960s, the Cof-flator, the first mechanical in-exsufflation device, went off the market as did the “Pneumobelt” 15 years later. There had been no major publications on it until 1991. However, like the “Pneumobelt”, mechanical in-exsufflation continues to be a practical, convenient, comfortable, and effective method to greatly increase cough flows to expel airway secretions and prevent pneumonia and respiratory failure and to permit extubation of ventilator unweanable patients to CNVS so that tracheotomy could be avoided indefinitely. Neither NIV and NVS should ever be considered in without considering mechanical in-exsufflation. In fact, publications reporting that NIV fails and tracheotomy is needed are simply failures to use NVS settings and, most importantly, failures to use mechanical in-exsufflation at the effective settings of 40 to 70 cm H2O via both noninvasive as well as invasive interfaces [100,101,102].


It is recommended that staff applying NVS receive appropriate training. Both specific knowledge and clinical experience are necessary. The training needs to be for health care professionals including physicians, nurses and physio/respiratory therapists, and most importantly, for the patient and family [103]. The time required for education and training in NIV/NVS and mechanical in-exsufflation is variable. Some authors have suggested that an initial session of two hours three times a month may provide adequate background [104]. With staff experience, sessions can then be distanced in time. Quantifying the experience and skill of a unit’s staff is challenging because individuals differ considerably and personnel changes can have important effects [105]. Optimal noninvasive management for daytime, as well as sleep support, requires all team members to be experienced. They must also be skilled in selecting appropriate devices and interfaces, fitting to optimize comfort, and adjusting the ventilator to efficiently alleviate respiratory distress and provide optimal settings. Nurses and physiotherapists need to be knowledgeable in regards to monitoring all stages of this in order to better train the patient and family.


Daytime NVS is crucial for patients with advanced ventilatory pump failure to avoid acute on chronic respiratory failure and invasive airway tubes. Precise criteria for daytime NIV/NVS initiation are totally unnecessary since patients extend nocturnal use into daytime hours on their own. Interfaces and access to mechanical in-exsufflation play key roles for NVS success. Glossopharyngeal breathing can also be a very effective means of daytime ventilatory support. Body ventilators may become a more prominent feature of daytime support with time. Further research in this emerging field is strongly warranted in order to further improve the quality of breathing and living for these fragile patients.

Availability of data and materials

Not available.



Noninvasive Ventilation


Continuous Noninvasive Ventilatory Support


Non-invasive Ventilatory Support


Vital Capacity


Mouthpiece Ventilation


  1. 1.

    Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J. 2003;47:3s–14s.

  2. 2.

    Friedman ML, Nitu ME. Acute respiratory failure in children. Pediatr Ann. 2018;47(7):e268–73.

    Article  Google Scholar 

  3. 3.

    Bach JR. Pathophysiology of paralytic/restrictive pulmonary syndromes. In: Bach JR, editor. Pulmonary rehabilitation: the obstructive and paralytic conditions. Philadelphia: Hanley & Belfus; 1996. p. 275–83.

    Google Scholar 

  4. 4.

    Bach JR. Physiology and pathophysiology of hypoventilation: ventilatory vs. oxygenation impairment. In: Bach JR, editor. Noninvasive mechanical ventilation. Philadelphia: Hanley & Belfus; 2002. p. 25–45.

    Google Scholar 

  5. 5.

    Carlucci A, Richard JC, Wysocki M, Lepage E, Brochard L. SRLF collaborative group on mechanical ventilation. Noninvasive versus conventional mechanical ventilation. An epidemiologic survey. Am J Respir Crit Care Med. 2001;163:874–80.

    Article  CAS  Google Scholar 

  6. 6.

    Mas A, Masip J. Noninvasive ventilation in acute respiratory failure. Int J Chron Obstruct Pulmon Dis. 2014;9:837–52. eCollection 2014.

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Demoule A, Girou E, Richard JC, Taillé S, Brochard L. Increased use of noninvasive ventilation in French intensive care units. Intensive Care Med. 2006;32:1747–55.

    Article  Google Scholar 

  8. 8.

    Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV). Thorax. 2005;60:1019–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Crescimanno G, Greco F, D'Alia R, Messina L, Marrone O. Quality of life in long term ventilated adult patients with Duchenne muscular dystrophy. Neuromuscul Disord. 2019:569-75.

  10. 10.

    Crimi C, Pierucci P, Carlucci A, Cortegiani A, Gregoretti C. Long -term ventilation in neuromuscular patients: review of concerns, beliefs, and ethical dilemmas. Respiration. 2019;97(3):185–96.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Perrin C, Rolland F, Berthier F, Duval Y, Jullien V. Noninvasive ventilation for acute respiratory failure in a pulmonary department. Rev Mal Respir. 2015;32(9):895–902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Bello G, De Pascale G, Antonelli M. Noninvasive ventilation. Clin Chest Med. 2016;37(4):711–21.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Gonzalez J, Sharshar T, Hart N, Chadda K, Raphaël JC, Lofaso F. Air leaks during mechanical ventilation as a cause of persistent hypercapnia in neuromuscular disorders. Intensive Care Med. 2003;29(4):596–602.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Sangeeta Mehta, And Nicholas S. Hill. Noninvasive Ventilation. Am J Respir Crit Care Med. 2001;163:2.

  15. 15.

    Hess DR. Noninvasive ventilation for neuromuscular disease. Clin Chest Med. 2018;39:437–47.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Toussaint M, Steens M, Wasteels G, Soudon P. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J. 2006;28:549–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017;10:CD004427.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Bach JR, Takyi SL. Physical medicine interventions to avoid acute respiratory failure and invasive airway tubes. PM R. 2015;7:871–7.

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Gomez-Merino E, Bach JR. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil. 2002;81:411–5.

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Vianello A, Corrado A, Arcaro G, Gallan F, Ori C, Minuzzo M, Bevilacqua M. Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil. 2005;84:83–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Morelot-Panzini C, Bruneteau G, Gonzalez-Bermejo J. NIV in amyotrophic lateral sclerosis: the ‘when’ and ‘how’ of the matter. Respirology. 2019;24(6):521–30.

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Khamankar N, Coan G, Weaver B, Mitchell CS. Associative increases in amyotrophic lateral sclerosis survival duration with non-invasive ventilation initiation and usage protocols. Front Neurol. 2018;9:578.

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest. 2006;130(6):1879–86.

    Article  Google Scholar 

  24. 24.

    Sheers N, Howard ME, Berlowitz DJ. Respiratory adjuncts to NIV in neuromuscular disease. Respirology. 2019;24(6):512–20.

    Article  Google Scholar 

  25. 25.

    Shneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J. 2002;20(2):480–7.

    Article  CAS  Google Scholar 

  26. 26.

    Hess DR. The growing role of noninvasive ventilation in patients requiring prolonged mechanical ventilation. Respir Care. 2012;57:900–18.

    Article  Google Scholar 

  27. 27.

    Finder DJ, Binkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170:456–65.

    Article  Google Scholar 

  28. 28.

    Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Colvin MK, Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17(5):445–55.

  29. 29.

    Bach JR. Noninvasive respiratory management of patients with neuromuscular disease. Ann Rehabil Med. 2017;41:519–36.

    Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Ramirez A, Delord V, Khirani S, Leroux K, Cassier S, Kadlub N,  et al. Interfaces for long-term noninvasive positive pressure ventilation in children. Intensive Care Med. 2012;38(4):655–62.

  31. 31.

    Chatwin M, Tan HL, Bush A, Rosenthal M, Simonds AK. Long term non-invasive ventilation in children: impact on survival and transition to adult care. PLoS One. 2015;1:10.

    Google Scholar 

  32. 32.

    Hamada S, Ishikawa Y, Aoyagi T, Ishikawa Y, Minami R, Bach JR. Indicators for ventilation use in Duchenne muscular dystrophy. Respir Med. 2011;105:625–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Butz M, Wollinsky KH, Wiedemuth-Catrinescu U, Sperfeld A, Winter S, Mehrkens HH, et al. Longitudinal effects of noninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003;82(8):597–604.

    PubMed  PubMed Central  Google Scholar 

  34. 34.

    Hess DR. Non invasive ventilation for acute respiratory failure. Respir Care. 2013;58:950–72.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Squadrone E, Frigerio P, Fogliati C, Gregoretti C, Conti G, Antonelli M, et al. Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance. Intensive Care Med. 2004;30(7):1303–10.

  36. 36.

    Luo F, Annane D, Orlikowski D, He L, Yang M, Zhou M, et al. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. Cochrane Database Syst Rev. 2017;12:CD008380.

  37. 37.

    Bach JR. Amyotrophic lateral sclerosis: communication status and survival with ventilatory support. Am J Phys Med Rehabil. 1993;72(6):343–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Bach JR. A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver. Chest. 1993;104(6):1702–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Bach JR. Point: is non-invasive ventilation always the most appropriate manner of long-term ventilation for infants with spinal muscular atrophy type 1? Yes, almost always? Chest. 2016;151(5):962–5.

    Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Bach JR. Noninvasive respiratory management of patients with neuromuscular disease. Ann Rehabil Med. 2017;41(4):1–20.

    Article  Google Scholar 

  41. 41.

    Villanova M, Brancalion B, Mehta AD. Duchenne muscular dystrophy: life prolongation by noninvasive ventilatory support. Am J Phys Med Rehabil. 2014;93(7):595–9.

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Toussaint M, Chatwin M, Soudon P. Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chron Respir Dis. 2007;4:167-77.

  43. 43.

    Bach JR. Noninvasive respiratory Management of Patients with neuromuscular disease. Ann Rehabil Med. 2017;41(4):519–38.

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care. 2006;51(8):896–911 discussion 911-2.

    PubMed  Google Scholar 

  45. 45.

    Tsolaki V, Pastaka C, Kostikas K, Karetsi E, Dimoulis A, Zikiri A, et al. Noninvasive ventilation in chronic respiratory failure: effects on quality of life. Respiration. 2011;81:402–10.

    Article  Google Scholar 

  46. 46.

    Bach JR, Martinez D. Duchenne muscular dystrophy: prolongation of survival by noninvasive interventions. Respir Care. 2011;56(6):744–50.

    Article  Google Scholar 

  47. 47.

    Pinto T, Chatwin M, Banfi P, Winck JC, Nicolini A. Mouthpiece ventilation and complementary techniques in patients with neuromuscular disease: a brief clinical review and update. Chron Respir Dis. 2017;14(2):187–93.

    Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Bach JR, Gonçalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137:1033–9; Prepublished online December 29, 2009.

    Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Bach JR, Goncalves MR, Rodriguez PL, Saporito L, Soares L. Cuff deflation: rehabilitation in critical care. Am J Phys Med Rehabil. 2014;93:719–23.

    Article  Google Scholar 

  50. 50.

    Sancho J, Servera E, Díaz JL, Banuls P, Marín J. Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival. Thorax. 2011;66:948–52.

    Article  Google Scholar 

  51. 51.

    Caggiano S, Khirani S, Dabaj I, Cavassa E, Amaddeo A, Arroyo JO, et al. Diaphragmatic dysfunction in SEPN1-related myopathy. Neuromuscul Disord. 2017;27(8):747–55. Epub 2017 Apr 26.

  52. 52.

    Georges M, Golmard JL, Llontop C, Shoukri A, Salachas F, Similowski T, et al. Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: single-Centre, retrospective, descriptive study in a national reference Centre. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(1–2):46–52.

  53. 53.

    Wood KE, Flaten AL, Backes WJ. Inspissated secretions: a life-threatening complication of prolonged noninvasive ventilation. Respir Care. 2000;45(5):491–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. 54.

    Dettenmeier PA, Jackson NC. Chronic hypoventilation syndrome: treatment with non-invasive mechanical ventilation. AACN Clin Issues Crit Care Nurs. 1991;2(3):415–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Banfi P, Volpato E, Bach JR. Efficacy of new intermittent abdominal pressure ventilator for post-ischemic cervical myelopathy ventilatory insufficiency. Multidiscip Respir Med. 2019;14:4.

    Article  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Bach JR, Radbourne M, Potpally N, Chiou M. A mechanical intermittent abdominal pressure ventilator: a case report. Am J Phys Med Rehabil. 2019. [Epub ahead of print].

  57. 57.

    Orlikowski D, Prigent H, Salva M-AQ, Heming N, Chaffaut C, Chevret S, et al. Prognostic value of nocturnal hypoventilation in neuromuscular patients. Neuromuscul Disord. 2017;27:326–30.

  58. 58.

    Ambrosino N, Confalonieri M, Crescimanno G, Vianello A, Vitacca M. The role of respiratory management of Pompe disease. Respir Med. 2013;107(8):1124–32.

    Article  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Grigg-Damberger MM, Wagner LK, Brown LK. Sleep hypoventilation in patients with neuromuscular diseases. Sleep Med Clin. 7(2012):667–87.

  60. 60.

    Ogna A, Quera Salva MA, Prigent H, Mroue G, Vaugier I, et al. Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. Sleep Breath. 2016;20(2):575–81.

  61. 61.

    Bedard ME, Mc Kim DA. Daytime mouthpiece for continuous noninvasive ventilation in individuals with amyotrophic lateral sclerosis. Respir Care. 2016;10:1341–8.

    Article  Google Scholar 

  62. 62.

    Nicolini A, Parrinello L, Grecchi B, Braido F, Baiardini I, Ghirotti C, et al. Diurnal mouthpiece ventilation and nocturnal non-invasive ventilation versus tracheostomy invasive ventilation in patients with amyotrophic lateral sclerosis. Panminerva Med. 2019. [Epub ahead of print].

  63. 63.

    Fiorentino G, Annunziata A, Gaeta AM, Lanza M, Esquinas A. Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degener Neurol Neuromuscul Dis. 2018;8:55-61.

  64. 64.

    Bach JR, Alba AS, Saporito LR. Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users. Chest. 1993;103(1):174–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. 65.

    Pinto T, Chatwin M, Banfi P, Winck JC, Nicolini A. Mouthpiece ventilation and complementary techniques in patients with neuromuscular disease: a brief clinical review and update. Chron Resp Dis. 2016.

  66. 66.

    Garuti G, Nicolini A, Grecchi B, Lusuardi M, Winck JC, Bach JR. Open circuit mouthpiece ventilation: concise clinical review. Rev Port Pneumol. 2014;20:211–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Khirani S, et al. Evaluation of ventilators for mouthpiece ventilation in neuromuscular disease. Respir Care. 2014;59:1329–37.

    Article  PubMed  PubMed Central  Google Scholar 

  68. 68.

    Nicolini A, Barlascini C, Piroddi IM, Garuti G, Banfi PI. Effectiveness and safety of mouthpiece ventilation and nocturnal non-invasive ventilation in patients with kyphoscoliosis: Short and long-term outcomes after an episode of acute respiratory failure. Rev Port Pneumol. 2016;22(2):75–81. Epub 2015 Dec 31.

    CAS  Article  PubMed  Google Scholar 

  69. 69.

    Carlucci A, Mattei A, Rossi V, Paracchini E, Santi Raineri SM, Gregoretti C. Ventilator settings to avoid nuisance alarms during mouthpiece ventilation. Resp Care. 2016;61:462–7.

    Article  Google Scholar 

  70. 70.

    Bach JR, Alba AS, Mosher R, Delaubier A. Intermittent positive pressure ventilation via nasal access in the management of respiratory insufficiency. Chest. 1987;92(7):168–70.

    Article  CAS  Google Scholar 

  71. 71.

    Bach JR, Alba AS. Management of chronic alveolar hypoventilation by nasal ventilation. Chest. 1990;97(1):52–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. 72.

    Goncalves MR, Bach JR, Ishikawa Y, Saporito L, Winck JC. Continuous noninvasive ventilatory support outcomes for neuromuscular disease: a multicentre collaboration and literature review. Pulmonol. 2019. [Epub ahead of print].

  73. 73.

    Navalesi P, Fanfulla F, Frigerio P, Gregoretti C, Nava S. Physiologic evaluation of noninvasive mechanical ventilation delivered with three types of masks in patients with chronic hypercapnic respiratory failure. Crit Care Med. 2000;28(6):1785–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. 74.

    Nava S, Navalesi P, Gregoretti C. Interfaces and humidification for noninvasive mechanical ventilation. Respir Care. 2009;54(1):71–84.

    PubMed  PubMed Central  Google Scholar 

  75. 75.

    Sferrazza-Papa GF, Di Marco F, Akoumianaki E, Brochard L. Recent advance in interfaces for non invasive ventilation : from bench studies to practical issues. Min Anestesiol. 2012;78:1146–53.

    CAS  Google Scholar 

  76. 76.

    Ogna A, Prignent H, Falaize L, Leroux K, Santos D, Vaugier I, et al. Bench evaluation of commercially available and newly developed interfaces for mouthpiece ventilation. Clin Resp J. 2018;12:890–4.

    Article  Google Scholar 

  77. 77.

    Bach J, Sortor SM, Saporito LR. Interfaces for non-invasive intermittent positive pressure ventilatory support in North America. Eur Respir Rev. 1993;3(12):254–9.

    Google Scholar 

  78. 78.

    Criner GJ, Travaline JM, Brennan KJ, Kreimer DT. Efficacy of a new full face mask for noninvasive positive pressure ventilation. Chest. 1994;106(4):1109–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. 79.

    Adamson JP, Lewis L, Stein JD. Application of abdominal pressure for artificial respiration. JAMA. 1959;169:1613–917.

    Article  CAS  Google Scholar 

  80. 80.

    Hill NS. Clinical applications of body ventilators. Chest. 1986;90:897-905.

  81. 81.

    Ayoub J, Milane J, Targhetta R, Prioux J, Chamari K, Arbeille P, Jonquet O, Bourgeois JM, Prefaut C. Diaphragm kinetics during pneumatic belt respiratory assistance: a sonographic study in Duchenne muscular dystrophy. Neuromuscul Disord. 2002;12(6):569–75.

    Article  PubMed  PubMed Central  Google Scholar 

  82. 82.

    Bach JR, Alba AS. Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest. 1991;99(3):630–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. 83.

    Yang GF, Alba A, Lee M, Khan A. Pneumobelt for sleep in the ventilator user: clinical experience. Arch Phys Med Rehabil. 1989;70(9):707–11 (confirmed).

    CAS  PubMed  PubMed Central  Google Scholar 

  84. 84.

    Miller HJ, Thomas E, Wilmot CB. Pneumobelt use among high quadriplegic population. Arch Phys Med Rehabil. 1988;69(5):369–72 (confirmed).

    CAS  PubMed  PubMed Central  Google Scholar 

  85. 85.

    Shneerson JM. Non-invasive and domiciliary ventilation: negative pressure techniques. Thorax. 1991;46:131–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. 86.

    Bach JR, Gonçalves MR, Hon A, Ishikawa Y, De Vito EL, Prado F, et al. Changing trends in the management of end-stage neuromuscular respiratory muscle failure: recommendations of an international consensus. Am J Phys Med rehabil. 2013;92:267–77.

  87. 87.

    Gilmartin ME. Body ventilators. Equipment and techniques. Respir Care Clin N Am. 1996;2(2):195–222.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. 88.

    Corrado A, Gorini M. Long-term negative pressure ventilation. Respir Care Clin N Am. 2002;8:545–57.

    Article  Google Scholar 

  89. 89.

    Glérant JC, Jounieaux V, Parreira VF, Dury M, Aubert G, Rodenstein DO. Effects of intermittent negative pressure ventilation on effective ventilation in normal awake subjects. Chest. 2002;122(1):99–107.

    Article  Google Scholar 

  90. 90.

    Sanna A, Veriter C, Stănescu D. Upper airway obstruction induced by negative-pressure ventilation in awake healthy subjects. J Appl Physiol (1985). 1993;75(2):546–52.

    Article  CAS  Google Scholar 

  91. 91.

    Bach JR, Penek J. Obstructive sleep apnea complicating negative pressure ventilatory support in patients with chronic paralytic/restrictive ventilatory dysfunction. Chest. 1991;99(6):1386–93.

    Article  CAS  Google Scholar 

  92. 92.

    Collier CR, Dail CW, Affeldt JE. Mechanics of glossopharyngeal breathing. J Appl Physiol. 1956;8:580–4.

    Article  CAS  Google Scholar 

  93. 93.

    Maltais F. Glossopharyngeal breathing. Am J Respir Crit Care Med. 2011;184:381.

    Article  Google Scholar 

  94. 94.

    LoMauro A, Banfi P, D'Angelo MG, Aliverti A. Glossopharyngeal breathing can allow a lung expansion greater than inspiratory capacity in muscular dystrophy. Eur Respir J. 2019.

  95. 95.

    Loring SH, O’Donnell CR, Butler JP, Lindholm P, Jacobson F, Ferrigno M. Transpulmonary pressures and lung mechanics with glossopharyngeal insufflation and exsufflation beyond normal lung volumes in competitive breath-hold divers. J Appl Physiol. 2007;102:841–6.

    Article  PubMed  Google Scholar 

  96. 96.

    Boussuges A, Gavarry O, Bessereau J, Coulange M, Bourc’his M, Rossi P. Glossopharyngeal insufflation and breath-hold diving: the more, the worse? Wilderness Environ Med. 2014;25:466–71.

    Article  PubMed  PubMed Central  Google Scholar 

  97. 97.

    Bianchi C, Carrara R, Khirani S, Tuccio MC. Independent cough flow augmentation by glossopharyngeal breathing plus table thrust in muscular dystrophy. Am J Phys Med Rehabil. 2014;93:43–8.

    Article  PubMed  PubMed Central  Google Scholar 

  98. 98.

    Bach JR, Bianchi C, Vidigal-lopes M, Turi S, Felisari G. Lung inflation by glossopharyngeal breathing and “air stacking” in Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2007;86(4):295–300.

    Article  PubMed  PubMed Central  Google Scholar 

  99. 99.

    Bach JR, Alba AS, Bodofsky E, Curran FJ, Schultheiss M. Glossopharyngeal breathing and noninvasive aids in the management of post-polio respiratory insufficiency. Birth Defects Orig Artic Ser. 1987;23(4):99–113.

    CAS  PubMed  PubMed Central  Google Scholar 

  100. 100.

    Bach JR, Sinquee D, Saporito LR, Botticello AL. Efficacy of mechanical insufflation-exsufflation in extubating unweanable subjects with restrictive pulmonary disorders. Respir Care. 2015;60(4):477–83.

    Article  PubMed  PubMed Central  Google Scholar 

  101. 101.

    Bach JR, Gonçalves MR, Hamdani I, Winck JC. Extubation of unweanable patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137(5):1033–9.

    Article  PubMed  PubMed Central  Google Scholar 

  102. 102.

    Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67(Suppl 1):i1–i40.

  103. 103.

    Habib K, Burnes KB, Ciobanu L, El-Khabib M, Nicolini A, Vargas N, et al. Non invasive ventilation: education and training: A narrative analysis and international consensus document. Adv Resp Med. 2019; ahead apub.

  104. 104.

    Simonds AK. Noninvasive ventilation support: a practical handbook. London: Arnold; 2001. p. 230–45.

    Google Scholar 

  105. 105.

    Nicolini A, Piroddi IMG, Barlascini C. How to enhance experience and skill of non invasive ventilation? Suggestions from the literature. Shortness Breath. 2015;4:19–25.

    Google Scholar 

Download references


No acknowledgements.


The authors declare no funding for this review.

Author information




PB and PP conception of the review, revised the literature and drafting the review, EV drafting the review and acquisition of the literature, AN and AL acquisition of the literature according with PB and PP, and DR and JB revised article and literature. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Paolo Banfi.

Ethics declarations

Ethics approval and consent to participate

Normally not available for review.

Consent for publication

We have the patient’s signed consent for the publication of the pictures.

Competing interests

The authors declare that they have no competing interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Banfi, P., Pierucci, P., Volpato, E. et al. Daytime noninvasive ventilatory support for patients with ventilatory pump failure: a narrative review. Multidiscip Respir Med 14, 38 (2019).

Download citation


  • Neuromuscular disorders
  • Respiratory failure
  • Noninvasive ventilation/ventilatory support
  • Mouthpiece ventilation
  • Intermittent abdominal pressure ventilation